Showing results (61-70 of 335) with videos related to
Sort By:
Pageof 34
Biochemical Pharmacology|November 14, 1997
Mechanisms of the inhibition of human erythrocyte pyridoxal kinase by drugsP Lainé-Cessac, A Cailleux, P AllainThrombosis Et Diathesis Haemorrhagica|June 30, 1975
Performances of an artificial reagent for the one-stage factor IX assayL Meunier, J P Allain, D FrommelRevue Neurologique|September 10, 2013
Executive functions in clinical and preclinical Alzheimer's diseaseP Allain, F Etcharry-Bouyx, C VernyJournal of Virology|November 17, 2001
Production and characterization of monoclonal antibodies specific for a conserved epitope within hepatitis C virus hypervariable region 1C Li, D Candotti, J P AllainTransfusion Medicine (Oxford, England)|September 11, 2002
Nucleic acid testing for emerging viral infectionsJ-P Allain, I Thomas, S SauledaThe Journal of Laboratory and Clinical Medicine|June 1, 1981
Immunochemical characterization of antibodies to factor VIII in hemophilic and nonhemophilic patientsJ P Allain, A Gaillandre, H LeeClinical Chemistry|January 1, 1989
Automated determination of cholinesterase activity in plasma and erythrocytes by flow-injection analysis, and application to identify subjects sensitive to succinylcholineP Lainé-Cessac, A Turcant, P AllainPresse Medicale (Paris, France : 1983)|May 11, 1985
[Articular and muscular hemorrhages in hemophilia A with anti-factor VIII antibodies. Treatment with selected batches of PPSB (factor IX concentrate)]F Verroust, C Moussard, J P AllainVirology|June 15, 1999
Broadly cross-reactive, high-affinity antibody to hypervariable region 1 of the hepatitis C virus in rabbitsD Shang, W Zhai, J P AllainBritish Journal of Haematology|May 1, 2001
Residual risk of transfusion in GhanaD Candotti, F Sarkodie, J P AllainPageof 34